St. Anna: CCRI researchers on the way to revolutionize molecular diagnosis of neuroblastoma

CCRI heads an EU-wide consortium for advancing liquid biopsy for the determination of individual tumor genomes into clinical practice. Together with ONTHETRRAC partners in Belgium, France and Germany, CCRI wants to improve diagnosis and monitoring.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)